Browsing by Author "Akdis, C"

Now showing 1 - 3 of 3
  • No Thumbnail Available
    Item
    BUILDING BRIDGES FOR INNOVATION IN AGEING: SYNERGIES BETWEEN ACTION GROUPS OF THE EIP ON AHA
    Bousquet, J; Bewick, M; Cano, A; Eklund, P; Fico, G; Goswami, N; Guldemond, NA; Henderson, D; Hinkema, MJ; Liotta, G; Mair, A; Molloy, W; Monaco, A; Monsonis-Paya, I; Nizinska, A; Papadopoulos, H; Pavlickova, A; Pecorelli, S; Prados-Torres, A; Roller-Wirnsberger, RE; Somekh, D; Vera-Munoz, C; Visser, F; Farrell, J; Malva, J; Ranberg, KA; Camuzat, T; Carriazo, AM; Crooks, G; Gutter, Z; Iaccarino, G; De Keenoy, EM; Moda, G; Rodriguez-Mañas, L; Vontetsianos, T; Abreu, C; Alonso, J; Alonso-Bouzon, C; Ankri, J; Arredondo, MT; Avolio, F; Bedbrook, A; Bialoszewski, AZ; Blain, H; Bourret, R; Cabrera-Umpierrez, MF; Catala, A; O'Caoimh, R; Cesari, M; Chavannes, NH; Correia-Da-Sousa, J; Dedeu, T; Ferrando, M; Ferri, M; Fokkens, WJ; Garcia-Lizana, F; Guérin, O; Hellings, PW; Haahtela, T; Illario, M; Inzerilli, MC; Carlsen, KCL; Kardas, P; Keil, T; Maggio, M; Mendez-Zorrilla, A; Menditto, E; Mercier, J; Michel, JP; Murray, R; Nogues, M; O'Byrne-Maguire, I; Pappa, D; Parent, AS; Pastorino, M; Robalo-Cordeiro, C; Samolinski, B; Siciliano, P; Teixeira, AM; Tsartara, SI; Valiulis, A; Vandenplas, O; Vasankari, T; Vellas, B; Vollenbroek-Hutten, M; Wickman, M; Yorgancioglu, A; Zuberbier, T; Barbagallo, M; Canonica, GW; Klimek, L; Maggi, S; Aberer, W; Akdis, C; Adcock, IM; Agache, I; Albera, C; Alonso-Trujillo, F; Guarcia, MA; Annesi-Maesano, I; Apostolo, J; Arshad, SH; Attalin, V; Avignon, A; Bachert, C; Baroni, I; Bel, E; Benson, M; Bescos, C; Blasi, F; Barbara, C; Bergmann, KC; Bernard, PL; Bonini, S; Bousquet, PJ; Branchini, B; Brightling, CE; Bruguière, V; Bunu, C; Bush, A; Caimmi, DP; Calderon, MA; Canovas, G; Cardona, V; Carlsen, KH; Cesario, A; Chkhartishvili, E; Chiron, R; Chivato, T; Chung, KF; D'Angelantonio, M; De Carlo, G; Cholley, D; Chorin, F; Combe, B; Compas, B; Costa, DJ; Costa, E; Coste, O; Coupet, AL; Crepaldi, G; Custovic, A; Dahl, R; Dahlen, SE; Demoly, P; Devillier, P; Didier, A; Dinh-Xuan, AT; Djukanovic, R; Dokic, D; Du Toit, G; Dubakiene, R; Dupeyron, A; Emuzyte, R; Fiocchi, A; Wagner, A; Fletcher, M; Fonseca, J; Fougère, B; Gamkrelidze, A; Garces, G; Garcia-Aymeric, J; Garcia-Zapirain, B; Gemicioglu, B; Gouder, C; Hellquist-Dahl, B; Hermosilla-Gimeno, I; Héve, D; Holland, C; Humbert, M; Hyland, M; Johnston, SL; Just, J; Jutel, M; Kaidashev, IP; Khaitov, M; Kalayci, O; Kalyoncu, AF; Keijser, W; Kerstjens, H; Knezovic, J; Kowalski, M; Koppelman, GH; Kotska, T; Kovac, M; Kull, I; Kuna, P; Kvedariene, V; Lepore, V; Macnee, W; Maggio, M; Magnan, A; Majer, I; Manning, P; Marcucci, M; Marti, T; Masoli, M; Melen, E; Miculinic, N; Mihaltan, F; Milenkovic, B; Millot-Keurinck, J; Mlinaric, H; Momas, I; Montefort, S; Morais-Almeida, M; Moreno-Casbas, T; Mösges, R; Mullol, J; Nadif, R; Nalin, M; Navarro-Pardo, E; Nekam, K; Ninot, G; Paccard, D; Pais, S; Palummeri, E; Panzner, P; Papadopoulos, NK; Papanikolaou, C; Passalacqua, G; Pastor, E; Perrot, M; Plavec, D; Popov, TA; Postma, DS; Price, D; Raffort, N; Reuzeau, JC; Robine, JM; Rodenas, F; Robusto, F; Roche, N; Romano, A; Romano, V; Rosado-Pinto, J; Roubille, F; Ruiz, F; Ryan, D; Salcedo, T; Schmid-Grendelmeier, P; Schulz, H; Schunemann, HJ; Serrano, E; Sheikh, A; Shields, M; Siafakas, N; Scichilone, N; Siciliano, P; Skrindo, I; Smit, HA; Sourdet, S; Sousa-Costa, E; Spranger, O; Sooronbaev, T; Sruk, V; Sterk, PJ; Todo-Bom, A; Touchon, J; Tramontano, D; Triggiani, M; Tsartara, SI; Valero, AL; Valovirta, E; Van Ganse, E; Van Hage, M; Van den Berge, M; Vandenplas, O; Ventura, MT; Vergara, I; Vezzani, G; Vidal, D; Viegi, G; Wagemann, M; Whalley, B; Wickman, M; Wilson, N; Yiallouros, PK; Zagar, M; Zaidi, A; Zidarn, M; Hoogerwerf, EJ; Usero, J; Zuffada, R; Senn, A; De Oliveira-Alves, B
    The Strategic Implementation Plan of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) proposed six Action Groups. After almost three years of activity, many achievements have been obtained through commitments or collaborative work of the Action Groups. However, they have often worked in silos and, consequently, synergies between Action Groups have been proposed to strengthen the triple win of the EIP on AHA. The paper presents the methodology and current status of the Task Force on EIP on AHA synergies. Synergies are in line with the Action Groups new Renovated Action Plan (2016-2018) to ensure that their future objectives are coherent and fully connected. The outcomes and impact of synergies are using the Monitoring and Assessment Framework for the EIP on AHA (MAFEIP). Eight proposals for synergies have been approved by the Task Force: Five cross-cutting synergies which can be used for all current and future synergies as they consider overarching domains (appropriate polypharmacy, citizen empowerment, teaching and coaching on AHA, deployment of synergies to EU regions, Responsible Research and Innovation), and three cross-cutting synergies focussing on current Action Group activities (falls, frailty, integrated care and chronic respiratory diseases).
  • No Thumbnail Available
    Item
    Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
    Klimek, L; Jutel, M; Akdis, C; Bousquet, J; Akdis, M; Bachert, C; Agache, I; Ansotegui, I; Bedbrook, A; Bosnic-Anticevich, S; Canonica, GW; Chivato, T; Cruz, AA; Czarlewski, W; Del Giacco, S; Du, H; Fonseca, JA; Gao, YD; Haahtela, T; Hoffmann-Sommergruber, K; Ivancevich, JC; Khaltaev, N; Knol, EF; Kuna, P; Larenas-Linnemann, D; Melén, E; Mullol, J; Naclerio, R; Ohta, K; Okamoto, Y; O'Mahony, L; Onorato, GL; Papadopoulos, NG; Pawankar, R; Pfaar, O; Samolinski, B; Schwarze, J; Toppila-Salmi, S; Shamji, MH; Ventura, MT; Valiulis, A; Yorgancioglu, A; Matricardi, P; Zuberbier, T
    The current COVID-19 pandemic influences many aspects of personal and social interaction, including patient contacts with health care providers and the manner in which allergy care is provided and maintained. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on inducing an appropriate immune response in the allergic patient. This manuscript outlines the EAACI recommendations regarding AIT during the COVID-19 pandemic and aims at supporting allergists and all physicians performing AIT in their current daily practice with clear recommendations on how to perform treatment during the pandemic and in SARS-CoV-2 infected patients.
  • No Thumbnail Available
    Item
    The Global Alliance against Respiratory Diseases (GARD) Country Report
    Yorgancioglu, A; Cruz, AA; Bousquet, J; Khaltaev, N; Mendis, S; Chuchalin, A; Bateman, ED; Camargos, P; Chavannes, NH; Bai, CX; Deleanu, D; Kolek, V; Kuna, P; Laurendi, G; Masjedi, MR; Mele, S; Mihaltan, F; Pinto, JR; Samolinski, B; Scalera, G; Sooronbaev, T; Tageldinla, MA; Tuyetlan, LT; Yusuf, O; Akdis, C; Baigenzhin, A; Cagnani, CB; Fletcher, M; Gemicioglu, B; Muhammed, Y; Sagra, H; To, T; Wagner, AHF